Silene firma
Silene firma · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Silene firma is a botanical species that has garnered increasing interest within the realm of ethnopharmacology. Recent scientific inquiries have begun to explore the potential therapeutic properties of this plant, specifically regarding its biological activity. Researchers are investigating whether its unique chemical constituents might offer benefits for managing complex health challenges such as prostate cancer. While much of the current understanding is rooted in preliminary studies, the plant represents a promising subject for oncology-related research. Understanding its mechanisms could eventually contribute to new approaches in supportive cancer care.
- Synonyms
- Silene Firma F. Pubescens · Silene Epilosa · 10 more
- Common names
- Not available
- Family
- Caryophyllaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Silene firma is a plant known by a diverse array of regional and linguistic identifiers. In Slavic contexts, it is commonly referred to as Дрёма крепкая or Смолёвка крепкая. Its presence in East Asian nomenclature is equally varied, appearing as フシグロ in Japanese scripts. Traditional Chinese names for the species include 坚硬女娄菜 and its variant 堅硬女蔞菜. These various names reflect the plant's widespread botanical recognition across different cultures.
Sources: Catalogue of Life (COL)
Synonyms
Silene firma is a botanical species that is frequently identified by various taxonomic synonyms in scientific literature. It is recognized under the name Elisanthe firma, reflecting different historical classifications. Researchers also refer to this plant as Melandrium firmum, a name that appears in several iterations. This includes specific variations such as Melandrium firmum f. pubescens and Melandrium apricum var. firmum. Additionally, the plant is documented as Melandrium apricum f. pubescens, illustrating the complex naming history associated with this species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Silene firma is a remarkable organism belonging to the kingdom Plantae. Within this vast biological realm, it is classified under the class Equisetopsida. It further resides in the order Caryophyllales, which highlights its evolutionary lineage. As a member of the genus Silene, it shares characteristics with many other specialized species. Ultimately, this plant is a distinguished representative of the family Caryophyllaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Caryophyllales |
| Family | Caryophyllaceae |
| Genus | Silene |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Silene firma is a plant species primarily found within the Asia-Temperate region. Its distribution is heavily concentrated across various parts of China, spanning from the North-Central to the South-Central territories. Furthermore, the species can be found throughout the Southeast regions of the country. Its geographical reach also extends into the northern reaches of Inner Mongolia. Finally, the plant is known to inhabit the Manchuria region, completing its widespread presence across these diverse landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Silene firma is a distinct herb characterized by its sturdy, self-supporting growth form. This plant typically reaches a modest stature, with heights generally ranging between 0.5 m and 1 m. In many specific instances, the species tends to stabilize at a minimum height of approximately 0.75 m. Its structural integrity allows it to stand upright without the need for external support. Overall, these physical dimensions define its presence within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Silene firma, also known as Melandrium firmum, contains bioactive phytochemicals like ecdysteroids that play a crucial role in treating prostate cancer. When combined with Achyranthes japonica in the BK002 formulation, its constituents demonstrate significant potential for targeted therapy. Research indicates that compounds such as ecdysterone and 20-hydroxyecdysone from this plant exhibit strong binding affinities to critical enzymes like 5α-reductase and CYP17. These interactions help reduce androgenic activity, which is a central driver of prostate cancer progression. Furthermore, the plant's bioactive components can interfere with oncogenic and immune evasion pathways by targeting proteins such as DNMT1, Dicer, PD-1, and PD-L1.